DVL2 and cancer: The anti-cancer effect of niclosamide was mediated by the downregulation of the Wnt/β-catenin signaling, which downregulated β-catenin, Cyclin D1, DVL2, and p-GSK3β proteins in the ALDH+ treated cells.